Armata Pharmaceuticals, Inc. (ARMP) › Operating IncomeArmata Pharmaceuticals, Inc. (ARMP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$12.38M2014: -$14.11M2015: -$10.23M2016: -$23.38M2017: -$16.16M2018: -$17.66M2019: -$19.75M2020: -$21.59M2021: -$23.82M2022: -$36.95M2023: -$40.89M2024: -$42.44M2025: -$36.63M-$36.63M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$36.63M+13.7%2024-$42.44M-3.8%2023-$40.89M-10.7%2022-$36.95M-55.1%2021-$23.82M-10.4%2020-$21.59M-9.3%2019-$19.75M-11.9%2018-$17.66M-9.3%2017-$16.16M+30.9%2016-$23.38M-128.6%2015-$10.23M+27.5%2014-$14.11M-13.9%2013-$12.38M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share